drugset / Trial / NCT07367971
Drug-Drug Interaction Study of ABP-671 in Gout Patients
NaSingle-groupOpen-labelTreatment
Summary
This is a open-Label, Within-Subject Drug-Drug Interaction Study of ABP-671 Added to Stable Allopurinol Therapy in Gout Patients. Pharmacokinetic (PK) interaction between ABP-671 and Allopurinol will be evaluated in participants who are on stable Allopurinol therapy.
Timeline
- Start
- 2026-01-23
- Primary completion
- 2026-07-31
- Completion
- 2026-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABP-671 | Unknown | — | — |
| Subject | Allopurinol | Small molecule | — | — |